These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 1520403

  • 21. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA, Zagorevskiĭ VA, Lopatina KI, Sokolova TV, Gankina EM.
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [Abstract] [Full Text] [Related]

  • 22. Membrane lipid peroxidation induces changes in gamma-[3H]aminobutyric acid transport and calcium uptake by synaptosomes.
    Palmeira CM, Santos MS, Carvalho AP, Oliveira CR.
    Brain Res; 1993 Apr 23; 609(1-2):117-23. PubMed ID: 8389646
    [Abstract] [Full Text] [Related]

  • 23. The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions.
    O'Carroll AM, Fowler CJ, Phillips JP, Tobbia I, Tipton KF.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Apr 23; 322(3):198-202. PubMed ID: 6408492
    [Abstract] [Full Text] [Related]

  • 24. Lipid peroxidation in mitochondrial membranes induced by enzymatic deamination of biogenic amines.
    Kagan VE, Smirnov AV, Savov VM, Prilipko LL, Gorkin VZ.
    Acta Physiol Pharmacol Bulg; 1983 Apr 23; 9(4):3-13. PubMed ID: 6677061
    [Abstract] [Full Text] [Related]

  • 25. Monoamine oxidase and semicarbazide sensitive amine oxidase activities in toad liver mitochondria.
    Senatori O, Nicotra A.
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988 Apr 23; 89(2):257-9. PubMed ID: 2899004
    [Abstract] [Full Text] [Related]

  • 26. [Modification of mitochondrial monoamine oxidase activity by certain amine inhibitors].
    Baumanis EA, Kalninia IE, Iriste AA, Gorkin VZ.
    Vopr Med Khim; 1981 Apr 23; 27(1):72-7. PubMed ID: 6781140
    [Abstract] [Full Text] [Related]

  • 27. Combined inhibition of serotonin uptake and oxidative deamination attenuates audiogenic seizures in DBA/2J mice.
    Sparks DL, Buckholtz NS.
    Pharmacol Biochem Behav; 1985 Nov 23; 23(5):753-7. PubMed ID: 4080761
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
    Ask AL, Ross SB.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec 23; 336(6):591-6. PubMed ID: 2965308
    [Abstract] [Full Text] [Related]

  • 29. Effect of diethylnitrosamine on monoamine oxidase in rat liver.
    Obata T, Yamashita H, Egashira T, Yamanaka Y.
    Jpn J Pharmacol; 1989 Jan 23; 49(1):151-3. PubMed ID: 2724679
    [Abstract] [Full Text] [Related]

  • 30. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM, Moskvitina TA, Gorkin VZ, Val'dman AV.
    Biull Eksp Biol Med; 1982 Nov 23; 94(11):29-31. PubMed ID: 7150732
    [Abstract] [Full Text] [Related]

  • 31. Evidence for the localization of hydrogen peroxide-stimulated cyclooxygenase activity in rat brain mitochondria: a possible coupling with monoamine oxidase.
    Seregi A, Serfözö P, Mergl Z.
    J Neurochem; 1983 Feb 23; 40(2):407-13. PubMed ID: 6401800
    [Abstract] [Full Text] [Related]

  • 32. The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue.
    Azzaro AJ, Amedro JB, Brown LM, Smith DJ, Williams GM.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul 23; 338(1):9-13. PubMed ID: 2467212
    [Abstract] [Full Text] [Related]

  • 33. Studies on human placental monoamine oxidase using mixed substrates.
    Oguchi K, Kobayashi S, Koide R.
    Jpn J Pharmacol; 1980 Apr 23; 30(2):157-64. PubMed ID: 7452967
    [Abstract] [Full Text] [Related]

  • 34. Deamination of 5-methoxytryptamine, serotonin and phenylethylamine by rat MAO in vitro and in vivo.
    Prozialek WC, Vogel WH.
    Life Sci; 1978 Feb 23; 22(7):561-9. PubMed ID: 272480
    [No Abstract] [Full Text] [Related]

  • 35. Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.
    Ask AL.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug 23; 327(1):56-63. PubMed ID: 6493351
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Features of the biochemical action of paraquat on oxidative deamination of biogenic amines and other nitrogen compounds].
    Amanov K, Mamadiev M, Khuzhamberdiev MA, Gorkin VZ.
    Vopr Med Khim; 1994 Aug 23; 40(4):22-8. PubMed ID: 7975374
    [Abstract] [Full Text] [Related]

  • 38. Activation of monoamine oxidase by high molecular weight fractions of human plasma.
    Wahlund LO, Sääf J, Ross SB, Wetterberg L.
    Acta Physiol Scand; 1984 Mar 23; 120(3):337-41. PubMed ID: 6741571
    [Abstract] [Full Text] [Related]

  • 39. [Possible change in the substrate specificity of the monoamine oxidase of rat brain and liver mitochondria in hyperoxia].
    Goroshinskaia IA, Bronovitskaia ZG.
    Vopr Med Khim; 1976 Mar 23; 22(4):558-62. PubMed ID: 1027243
    [Abstract] [Full Text] [Related]

  • 40. [The effect of pyrazidol on the catalytic properties of monoamine oxidases in pressure-chamber hypoxia in rats].
    Zelenshchikova VA, Min'ko IuV, Shatemirova KK.
    Aviakosm Ekolog Med; 1993 Mar 23; 27(2):57-60. PubMed ID: 8012304
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.